Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fabrazyme in Lactating Mothers with Fabry Disease
NCT00230607Phase 4Terminated
- Sponsor
- Sanofi
- Start
- May 2006
- Primary completion
- Feb 2024
- Modality
- Replacement Enzymes
- Countries
- 3
01
Overview
A Phase 4 trial of agalsidase beta in Fabry disease (FD), sponsored by Sanofi. Started May 2006; status: terminated.
02
Drugs
agalsidase beta
03
Conditions
Fabry disease (FD)
Beyond the preview
Go deeper on NCT00230607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00230607.